CCI Photonics Receives Investment

CCI Photonics, a PBL and Lancaster University technology startup that plans to help clinicians prescribe antibiotics more effectively, has become one of the first companies to receive £200k investment from PraeSeed, a six-week cohort investing programme for early-stage businesses.

CCI Photonics will use the funding to further trial its InfectiScan^TM device, a point-of-care test that can be used by GPs and pharmacists to accurately detect infection types in patients, so the best antibiotic can be prescribed.

Please click here for the full press release.